The company will present crucial safety advancements at the virtual event as a part of its continued pursuit of advancing the world of healthcare
Dubai, United Arab Emirates:The Dubai branch of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology organization, is all set to showcase industry-leading and cutting-edge MedTech innovations at the 17th edition of the Patient Safety Congress scheduled from 4th – 6th November 2021.
BD positions patient safety at the helm of its efforts. The company strives to support the region’s healthcare providers in their aspirations to achieve sustainable practices by delivering advanced medical technology, expertise, and solutions. At the Patient Safety Congress, BD will highlight the importance of medical technologies that prevent healthcare-associated infections, foster safer medical procedures, address the need to detect several life-threatening pathogens, identified and tested for antibiotic susceptibility for enhanced treatment management decisions.
“The situation that we have been through in the last two years has demonstrated that healthcare is at the heart of the region’s growth and has highlighted the necessity for advanced MedTech adoption to strengthen the health sector’s standing. Avenues like the Patient Safety Congress are critical for raising awareness and enabling conversations about the needs and improvements that are required for the future of patient safety.” said Maher Elhassan, Vice President & General Manager, BD Middle East, North Africa & Turkey. “As part of our mission to advance the world of health, our participation at the Patient Safety Congress 2021 reaffirms the company’s commitment to the healthcare sector by showcasing our latest innovations in patient care, safety, diagnostic accuracy, automation, and more.”
BD will also be partaking in two webinars at the virtual event, titled Patient Safety, shared responsibility
and Connecting & Optimizing a Patient’s Journey to Safety. The first webinar will provide the audience with a better look into BD’s quality-driven background that enables the sustainable culture of patient safety while maintaining quality efficiency. The second session will showcase an immersive virtual experience at the BD Centre for Safety & Clinical Excellence.
It is estimated1 that 1 in 10 patients is harmed while receiving unsafe care and research2 shows that 30-70% of medical errors are preventable with the adoption of advanced MedTech solutions. To address these challenges amongst others, BD continues to focus heavily on improving diagnostic accuracy and efficiency to set patients on the right clinical path, delivering an enhanced error-free experience in their journey.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical processes for health care providers. BD and its 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to accurately detect disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.